| Literature DB >> 33651342 |
A Morotti1, I Sollaku1, F Franceschini2,3, I Cavazzana2, M Fredi2,3, E Sala4, G De Palma5,6.
Abstract
KEY MESSAGES: • Occupational exposure to free crystalline silica and tobacco smoking are associated with an increased risk rheumatoid arthritis, with the evidence of an interaction in seropositive subjects. • Further studies in the field are needed to support such association We carried out a systematic search for all published epidemiological studies concerning the association between occupational exposure to free crystalline silica (FCS) and subsequent development of rheumatoid arthritis (RA). A meta-analysis was conducted on relevant studies. We searched PubMed and Embase, search engines, for original articles published (from 1960 to November 2019) in any language. In addition, we also searched reference lists of included studies manually for additional relevant articles. Finally, twelve studies were included in the meta-analysis (seven case-control cases and five cohort studies). The odds risks and 95% confidence interval (CI) were calculated using a random effect meta-analysis. A primary meta-analysis (using a random effect model)-regarding RA risk in subjects exposed to FCS-yelled to an overall OR of 1.94 (95% CI 1.46-2.58). We also conducted three further meta-analysis, taking into account the presence of autoantibodies (anti-RF or anti-ACPA) and smoking habits and found a significant association between FCS and RA in both seropositive and seronegative subjects (OR 1.74, 95% CI 1.35-2.25 and OR 1.23, 95% CI 1.06-1.4, respectively) and in seropositive subjects which were smokers (OR 3.30, 95% CI 2.40-4.54). The studies that have investigated the association between RA and occupatational exposure to FCS are still scarce and the heterogeneity between the studies remains high. Some critical limitations have been identified within studies, among which, the methods for assessing exposure stand out. Although with due caution, our results confirm the hypothesis of an association between occupational exposure to FCS and RA development. There was an interaction between FCS and tobacco smoking in RA seropositive workers.Entities:
Keywords: Free crystalline silica; Meta-analysis; Rheumatoid arthritis; Silica
Mesh:
Substances:
Year: 2021 PMID: 33651342 PMCID: PMC8994741 DOI: 10.1007/s12016-021-08846-5
Source DB: PubMed Journal: Clin Rev Allergy Immunol ISSN: 1080-0549 Impact factor: 8.667
Literature search strategy
| Database | Search strategy |
|---|---|
| PubMed | (cohort studies[mesh:noexp] OR followup studies[mesh:noexp] OR prospective studies[mesh:noexp] OR retrospective studies[mesh:noexp] OR cohort[TIAB] OR prospective[TIAB] OR retrospective[TIAB] OR “Case-Control Studies”[Mesh:noexp] OR "retrospective studies"[mesh:noexp] OR “Control Groups”[Mesh:noexp] OR (case[TIAB] AND control[TIAB]) OR (cases[TIAB] AND controls[TIAB]) OR (cases[TIAB] AND controlled[TIAB]) OR (case[TIAB] AND comparison*[TIAB]) OR (cases[TIAB] AND comparison*[TIAB]) OR “control group”[TIAB] OR “control groups”[TIAB] OR occupational diseases [MH] OR occupational exposure [MH] OR occupational exposure* [TW] OR “occupational health” OR “occupational medicine” OR work-related OR working environment [TW] OR at work [TW] OR work environment [TW] OR occupations [MH] OR work [MH] OR workplace* [TW] OR workload OR occupation* OR worke* OR work place* [TW] OR work site* [TW] OR job* [TW] OR occupational groups [MH] OR employment OR worksite* OR industry) AND (“Rheumatoid Arthritis” OR RA) |
| Embase | ('rheumatoid arthritis'/exp OR 'rheumatoid arthritis' OR 'ra' OR ra) AND ('silica'/exp OR 'silica') OR 'silica'/exp OR silica) AND ('case control study'/exp OR 'case control study') OR 'cohort analysis'/exp OR 'cohort analysis' OR 'observational study'/exp OR 'observational study' OR 'prospective study'/exp OR 'prospective study' OR 'retrospective study'/exp OR 'retrospective study' |
Fig. 1Flow chart of search and selection of studies included in the review and meta-analysis
RA studies included in the Systematic Review and meta-analysis
| Study ID | Author | Year | Country | Year | Design | Type of exposure | Exposure assessment | No. of observed cases | Effect size (95% CI) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Ilar [ | 2019 | Sweden | 1996–2013 | CC | Occupational – not better specified | JEMs | 742 cases/5235 controls (678 men; 64 women) | Any RA: OR 1.3 (1.2–1.5) RA+ : RR 1.28 (1.02–1.61) RA−: RR 1.46 (1.03–2.07) |
| 2 | Schmajuk [ | 2019 | USA | 2019 | CO | Mainly coal mining work | Exposure data were self-reported during a telephone questionnaire | 556 silica-exposed male workers | Any RA: OR 2.1 (1.1–3.9) |
| 3 | Vihlborg [ | 2017 | Sweden | 1930–2013 | CO | Iron foundries | A mixed model was used to calculate silica exposure, and individual silica exposures were used to compute dose responses | 2187 silica-exposed male workers | SIR 2.59 (1.24–4.76) |
| 4 | Blanc [ | 2015 | Sweden | 1997–2010 | CO | Construction work | JEMs | 195 silica-exposed male workers | Any RA: RR 1.33 (1.11–1.60) RA+ : RR 1.28 (1.02–1.61) RA−: RR 1.46 (1.03–2.07) Smoking : Any RA: RR 1.99 (1.66–2.40) RA+ : RR 2.41 (1.89–3.07) RA−: RR 1.52 (1.10–2.12) |
| 5 | Yahya [ | 2014 | Malaysia | 2005–2009 | CC | Stone dust, rock drilling, stone crushing | In-person interview according to an extensive questionnaire The questions concerning silica exposure covered time aspects of exposure (when and how long) as well as exposure intensity | 14 cases/12 controls | Any RA: OR 2.0 (0.9–4.6) RA+ : OR 2.4 (1.0–5.6) RA−: OR 0.9 (0.2–4.5) RA+ : OR 7.5 (2.3 -24.2) |
| 6 | Makol [ | 2011 | USA | 1985–2006 | CO | Various including foundry work and sandblasting | 30-45 min telephone interview (if the individual was deceased, a next-of-kin was interviewed). Addition medical records, radiographs, laboratory data were also collected | 1022 cases diagnosed with Silicosis. (only for the outcome: 24 case of SLE) | Any RA: RR 2.26 (1.57–3.25) |
| 7 | Stolt [ | 2009 | Sweden | 1996–2006 | CC | Stone dust, rock drilling, stone crushing | Exposure data were self-reported using a questionnaire | 80 cases/69 controls | Any RA: OR 1.39 (0.98–1.96) RA+ : OR 1.67 (1.13–2.48) RA−: OR 0.98 (0.57–1.66) Smoking : Any RA: OR 2.35 (1.46–3.80) RA+ : OR 4.08 (2.31–7.21) RA−: OR 1.16 (0.56–2.39) |
| 8 | Gold [ | 2007 | USA | 1984–1999 | CC Mortality-Death certificates data | Among 509 different jobs mainly hand painting, hand coating and hand decorating occupations | JEMs | 35,730 cases/260,632 controls | Any RA: OR 0.99 (0.94–1.03) |
| 9 | Stolt [ | 2004 | Sweden | 1996–2001 | CC | Stone dust, rock drilling, stone crushing | Exposure data were self-reported using a questionnaire | 21 cases/11 controls | Any RA: OR 3.0 (1.2–7.6) RA+ : OR 3.5 (1.1–11.2) RA−: OR 1.7 (0.3–9.3) Smoking : Any RA: OR 3.7 (1.7–8.1) RA+ : OR 5.4 (2.1–14.0) RA−: OR 1.6 (0.4–7.2) |
| 10 | Calvert [ | 2003 | USA | 1982–1995 | CC Mortality-Death certificates data | Occupational exposure to FCS not better specified (in general mining and dusty trades) | JEMs | 15 cases/20 controls | Any RA: OR 3.75 (1.92–7.32) |
| 11 | Brown [ | 1997 | Sweden-Denmark | 1965–1983 | CO Mortality-Death certificates data | A review of Swedish computerized hospital diagnoses with diagnostic codes for both silicosis and SLE. The type of exposure was not better specified | A review of Swedish computerized hospital diagnoses with diagnostic codes for both silicosis and SLE. The exposure assessment was not better specified | 57 cases (only for the outcome: 44 cases of SLE) | Any RA: RR 8.1 (5.9–10.82) |
| 12 | Sluis-Cremer [ | 1986 | South Africa | 1967–1979 | CC | Gold mines | JEMs | 96 cases/157 controls | RA+ : OR 5 (1.99–12.56) RA−: OR 1.44 (0.44–4.73) NOT TESTED: OR 2.25 (0.78–6.43) |
CC case control, JEM job-exposure matrix
Fig. 2Meta-analysis of all the selected studies on occupational exposure to FCS and RA
Fig. 3Meta-analysis of studies including seropositive (RA+) RA patients
Fig. 4Meta-analysis of studies including seronegative (RA−) RA patients
Fig. 5Meta-analysis of studies investigating interaction between occupational exposure to FCS, smoking habits, and seropositive (RA+) RA patients